Biliary Tract Cancer Clinical Trials in Freiburg im Breisgau, Baden-Wurttemberg

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer